J. Adams
Molecular Biology · Science · 2002–2016
A researcher in the Science corpus: 8 papers; trusts 7 researchers and is trusted by 12 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 39 citations into it; #3,043 of 17,773 by trust here, #3,712 by citations
- Oncology — 31 citations into it; #132 of 1,698 by trust here, #371 by citations
- Cancer Research — 8 citations into it
- Epidemiology — 7 citations into it
- Hematology — 7 citations into it; #35 of 225 by trust here, #178 by citations
- Cell Biology — 6 citations into it
Whom J. Adams trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- T. Hideshima
- P. Richardson
- A. Baldwin
- A. Goldberg
- Andrew W. Murray
- Julian Adams
- P. Chène
- M. Karin
- S. Hawley
- D. Hardie
Who trusts J. Adams overall
- Marcy J. Balunas
- A. Kinghorn
- Stephen W. Fesik
- Chikashi Nakanishi
- Daniela Hoeller
- Y. Ye
- I. Weinstein
- Ivan Dikic
- S. Lecker
- F. Janku
Papers from J. Adams's perspective
Ordered by how strongly the researchers J. Adams trusts endorse each paper. Same corpus, a different order for every researcher.
- A phase 2 study of bortezomib in relapsed, refractory myeloma. (New England Journal of Medicine)
- An activating mutation in the γ1 subunit of the AMP‐activated protein kinase
- AMP‐activated protein kinase: the energy charge hypothesis revisited (Bioessays)
- Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341. (Blood)
- Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. (Biochemical Journal)
- A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. (Science)
- Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase (Nature)
- The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling Pathways* (Journal of Biological Chemistry)
- CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. (Journal of Clinical Investigation)
- Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase (Nature Medicine)
Their papers
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer (2009) — 3,151 citations
- The proteasome: a suitable antineoplastic target (2004) — 1,235 citations
- The development of proteasome inhibitors as anticancer drugs. (2004) — 788 citations
- Development of the Proteasome Inhibitor Velcade™ (Bortezomib) (2004) — 658 citations
- Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies. (2002) — 765 citations
- Overcoming Resistance to Checkpoint Blockade Therapy by Targeting PI3K-γ in Myeloid Cells (2016) — 786 citations
- Intrasteric control of AMPK via the γ1 subunit AMP allosteric regulatory site (2004) — 164 citations
- Flexibility, functionality and hydrophobicity of bovine β-lactoglobulin ☆ (2002) — 87 citations